title: Melioidosis acquired by traveler to Nigeria.
abstract: We describe melioidosis associated with travel to Nigeria in a woman with diabetes, a major predisposing factor for this infection. With the prevalence of diabetes projected to increase dramatically in many developing countries, the global reach of melioidosis may expand.
authors.affiliation: Guy's and St. Thomas' National Health Service Trust, London, UK.
authors.forename: Alex P
authors.initials: AP
authors.lastname: Salam
authors.forename: Nisa
authors.initials: N
authors.lastname: Khan
authors.forename: Henry
authors.initials: H
authors.lastname: Malnick
authors.forename: Dervla T D
authors.initials: DT
authors.lastname: Kenna
authors.forename: David A B
authors.initials: DA
authors.lastname: Dance
authors.forename: John L
authors.initials: JL
authors.lastname: Klein
mesh_terms: D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016957:Burkholderia pseudomallei / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D004269:DNA, Bacterial / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D005260:Female; D005334:Fever; D006801:Humans; D008554:Melioidosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission; D000077731:Meropenem; D008875:Middle Aged; D058885:Multilocus Sequence Typing; D009549:Nigeria; D010802:Phylogeny; D012307:Risk Factors; D013845:Thienamycins / Q000008:administration & dosage / Q000627:therapeutic use; D014195:Travel; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D013845:Thienamycins; D019980:Amoxicillin-Potassium Clavulanate Combination; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000077731:Meropenem